3119468-32-2
Chemical Structure
MYX1715 analog 1
- CAS No.: 3119468-32-2
- Formula:C27H29F2N5O3
- Molecular Weight:509.56
IUPAC Name: (4-(2-(2,3-difluoro-6-(3-((methylamino)methyl)imidazo[1,2-a]pyridin-6-yl)phenoxy)ethyl)-1,5-dimethyl-1H-pyrazol-3-yl)(1-(hydroxymethyl)cyclopropyl)methanone
InChIKey: FFPDGGKPIWYZMJ-UHFFFAOYSA-N
SMILES: O=C(C1=NN(C(=C1CCOC=2C(F)=C(F)C=CC2C=3C=CC4=NC=C(N4C3)CNC)C)C)C5(CO)CC5
Biological Activity: MYX1715 analog 1 is an analog of MYX1715 (HY-164285). MYX1715 analog 1 is an N-myristoyltransferase (NMT) inhibitor that inhibits protein myristoylation modification. MYX1715 analog 1 can be conjugated to targeting antibodies via cleavable or non-cleavable linkers for use as an ADC cytotoxin. MYX1715 analog 1 is used in the development of drugs targeting tumor-associated antigens[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MYX1715 analog 1 | MYX1715 analog 1 is an analog of MYX1715 (HY-164285). MYX1715 analog 1 is an N-myristoyltransferase (NMT) inhibitor that inhibits protein myristoylation modification. MYX1715 analog 1 can be conjugated to targeting antibodies via cleavable or non-cleavable linkers for use as an ADC cytotoxin. MYX1715 analog 1 is used in the development of drugs targeting tumor-associated antigens. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
